What is step therapy, and how do you get around it?

Benefily Team19 July 20268 min read

An older pharmacy customer discussing medication options with a pharmacist at the counter

Your pharmacist says the drug your doctor prescribed needs step therapy first, and you leave with no idea what that actually means. Step therapy is a specific kind of prior authorization: your plan wants proof that a cheaper, similarly effective drug either failed or was unsuitable for you before it will pay for the one you were actually prescribed. This guide explains the mechanism in plain terms, what your prescriber needs to submit for each scenario, and where people typically trip up. It draws on Medicare's own exception rules and a 2025 formulary review showing how deeply step therapy is built into Part D prior authorization criteria.

Key takeaways

Step therapy means trying a cheaper, similarly effective drug first — it's a stricter cousin of plain prior authorization, not the same thing.
Three situations clear it: you've never tried the preferred drug and have a documented reason not to, you tried it and it failed, or you can take it but not safely.
Your prescriber, not you, files a supporting statement. It has to state medical necessity, not just your preference.
A step therapy exception is legally a formulary exception, so it runs on the standard coverage determination clock: 72 hours for a routine request, 24 hours if waiting could seriously harm you.
Step therapy is often folded quietly into a plan's prior authorization criteria rather than flagged separately, so a request that looks like an ordinary PA denial may actually need a step therapy argument to clear it.
If the exception is refused, you can appeal — a redetermination filed with the plan within 60 days of the denial notice.

What step therapy actually means

Step therapy is a rule your Medicare Part D plan attaches to certain drugs on its formulary: before it will pay for the drug your prescriber actually chose, you have to try a cheaper, clinically similar drug first, and that drug has to fail or turn out to be unsuitable for you. Plans usually call the cheaper option the preferred or first-line drug, and the one you were prescribed the second-line, or "step 2," drug. The logic is straightforward enough: if a less expensive medicine works just as well for most people with your condition, the plan wants evidence that it doesn't work for you specifically before agreeing to pay more.

It's easy to confuse this with a plain prior authorization request, and the confusion matters because the fix is different for each. A standard prior authorization applies to a drug regardless of what you've tried before; your prescriber only has to justify why you need that specific medicine now. Step therapy adds a condition on top of that: it isn't enough to justify the drug in isolation, your prescriber also has to address the step you were meant to take first, or explain in writing why you shouldn't have to take it. If you want the fuller picture of how prior authorization works in general, What is prior authorization? covers the coverage determination process from start to finish.

The three routes through a step therapy requirement

Whatever the drug, a step therapy exception request only ever needs to establish one of three things. Your prescriber decides which applies to you, then documents it for the plan.

Your situation	What your prescriber submits
You've never tried the preferred drug	A statement giving a specific, documented clinical reason you shouldn't try it now — a contraindication, an allergy, or an interaction with another drug you're already on
You've already tried the preferred drug and it failed	The drug's name, the dose and dates you took it, and the specific outcome — insufficient effect, or a side effect you actually experienced
You can take the preferred drug, but not safely or effectively	Clinical evidence tying your particular diagnosis or condition to why the preferred drug is likely to be less effective or cause adverse effects for you

Step therapy scenarios and what your prescriber needs to submit for each.

What actually counts as sound documentation

Medicare's rule here is specific: the prescriber's supporting statement has to be backed by sound clinical evidence, not preference. A note saying the patient would rather have the newer drug won't clear a step therapy flag. A note saying the patient's condition makes the preferred alternative likely to be less effective, with the reasoning spelled out, will. This is also why a step therapy exception is filed in your prescriber's name rather than yours: the plan is asking a clinical question, and only your prescriber's judgement, in writing, answers it.

Same clock as prior authorization, a different starting gun

A step therapy exception is legally classed as a formulary exception — the same mechanism used to ask for a drug that isn't on the formulary at all — so it runs on the ordinary Part D coverage determination clock. A standard request must be decided within 72 hours of your prescriber submitting it; an expedited request, filed when waiting could seriously jeopardise your health, gets 24 hours. Miss either deadline and the plan has, in effect, denied the request by default, which lets you move straight to an appeal rather than waiting indefinitely.

Just how common step therapy actually is depends on the drug class, and it's more widespread than it looks, because plans frequently fold it into their prior authorization criteria rather than flagging it as its own separate rule.

“For covered PsA drugs, PDPs apply embedded ST 50% of the time and MA-PDs apply embedded ST 58% of the time.”
— Avalere Health, Part D Prior Authorization Policies May Include Step Therapy (April 2025)

That finding comes from a 2025 review of Part D and Medicare Advantage formularies for psoriatic arthritis and multiple sclerosis drugs specifically, but the pattern it shows is broader: for many high-cost drugs, a prior authorization denial and a step therapy denial can look identical from where you're sitting, even though clearing one requires a different argument than clearing the other. Checking the actual formulary row for your drug, rather than assuming which restriction applies, is worth the five minutes it takes.

Common mistakes

Describing a past trial vaguely, as "didn't work," instead of giving the drug name, dose, dates, and specific outcome. Plans routinely reject statements missing any of the four.
Assuming a failure with a similar drug that isn't the exact one your plan lists as preferred still counts. Check the formulary row first; a near-miss substitute usually doesn't satisfy the requirement.
Treating the exception request as an update to an earlier prior authorization instead of a new filing. It has its own 72-hour or 24-hour clock, which starts only once your prescriber actually submits the statement.
Expecting the pharmacist to clear it at the counter. Only your prescriber can submit the supporting statement, and only the plan can approve it.
Leaving out medical necessity. CMS requires the statement to establish that the step is clinically inappropriate for you, not simply that you'd prefer to skip it.

A worked example: metformin, then Mounjaro

Say a plan member has type 2 diabetes, and their endocrinologist prescribes Mounjaro (tirzepatide). The plan's formulary flags Mounjaro for step therapy: it wants proof that metformin, the standard first-line drug, was tried first. This is an illustrative case, not a real patient, but it's a realistic one. The patient took metformin for eight months at the maximum dose they could tolerate, and their blood sugar stayed above target throughout, with gastrointestinal side effects severe enough that their prescriber had already reduced the dose twice.

The prescriber's supporting statement names the drug, gives the dose and dates trialled, and records two distinct outcomes: inadequate control despite maximum tolerated dose, and a documented adverse effect. That's a "tried and failed" case — the second row in the table above — and it's usually enough for the plan to approve the exception directly once its clinical reviewer checks the statement, without needing a formal appeal at all.

If the exception is refused

A refusal notice has to explain the specific reason and how to challenge it. The first step is a redetermination, requested from the plan within 60 days of the denial. Appeal rates across Medicare Advantage prior authorization generally are low, but the outcomes for people who do appeal tend to be favourable, which suggests it's worth doing rather than accepting a first refusal as final, particularly when your prescriber's original statement was thorough.

Frequently asked questions

What's the difference between step therapy and prior authorization?

Prior authorization applies to a drug regardless of what you've tried before; your prescriber just justifies why you need it. Step therapy adds a further condition: your prescriber also has to show you tried (or had a documented reason not to try) a cheaper alternative first.

How long does a step therapy exception request take to be decided?

The same clock as any other Part D coverage determination: 72 hours for a standard request, or 24 hours if your prescriber states that waiting could seriously harm your health.

Does trying a similar drug count, even if it isn't the exact one my plan lists as preferred?

Usually not. Step therapy requirements are typically tied to the specific drug named on the formulary row, so a trial of a different drug in the same class often doesn't satisfy it. Check the formulary entry for your drug before assuming a past trial counts.

Can my doctor just say they don't want me on the cheaper drug?

No. Medicare requires the supporting statement to establish medical necessity — a documented clinical reason the preferred drug is likely to be less effective or cause adverse effects for you — not simply a preference for the newer drug.

What happens if my step therapy exception is denied?

You can ask the plan for a redetermination within 60 days of the denial notice. Make sure the appeal includes any clinical detail the notice specifically asked for, since incomplete redeterminations are a common reason appeals stall.

Related on Benefily

Sources

Administrative information only. Benefily reports what a payer has published in its own prior-authorization policy as of the effective date shown. It is not medical advice, not a coverage or payment guarantee, and not an authorization. Requirements vary by plan, place of service and member benefits — always verify with the payer before rendering service.